Left ventricular systolic dysfunction precipitated by verapamil in cardiac amyloidosis.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 8339658.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Cardiac amyloidosis produces a restrictive cardiomyopathy with impaired diastolic function. We report a case in which low-dose verapamil resulted in marked worsening of congestive heart failure, as a result of a profound negative inotropic effect. Withdrawal of verapamil therapy demonstrated a return of systolic function to normal with improvement in heart failure. We postulate that patients with cardiac amyloidosis may be exceptionally sensitive to the negative inotropic effects of calcium-channel blockers either because of abnormal binding to amyloid fibrils or because their usual vasodilator effects are blunted.
Medical subject headings
- Amyloidosis
- Cardiomyopathies
- Heart Failure
- Ventricular Function, Left
- Verapamil